Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 322

1.

Charting the Path Forward for Risk Prediction in Liver Transplant for HCC: International Validation of HALTHCC amongst 4,089 patients.

Firl DJ, Sasaki K, Agopian VG, Gorgen A, Kimura S, Dumronggittigule W, McVey JC, Iesari S, Mennini G, Vitale A, Finkenstedt A, Onali S, Hoppe-Lotichius M, Vennarecci G, Manzia TM, Nicolini D, Avolio AW, Agnes S, Vivarelli M, Tisone G, Ettorre GM, Otto G, Tsochatzis E, Rossi M, Viveiros A, Cillo U, Markmann JF, Ikegami T, Kaido T, Lai Q, Sapisochin G, Lerut J; European Hepatocellular Cancer Liver Transplant Study Group, Aucejo FN.

Hepatology. 2019 Jun 27. doi: 10.1002/hep.30838. [Epub ahead of print]

PMID:
31243778
2.

Hepatocellular carcinoma recurrence after acute liver allograft rejection treatment: A multicenter European experience.

Lai Q, Iesari S, Finkenstedt A, Hoppe-Lotichius M, Foguenne M, Lehner K, Otto G, Lerut J.

Hepatobiliary Pancreat Dis Int. 2019 May 20. pii: S1499-3872(19)30092-X. doi: 10.1016/j.hbpd.2019.05.006. [Epub ahead of print]

PMID:
31151807
3.

The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation.

Lai Q, Vitale A, Iesari S, Finkenstedt A, Mennini G, Onali S, Hoppe-Lotichius M, Manzia TM, Nicolini D, Avolio AW, Mrzljak A, Kocman B, Agnes S, Vivarelli M, Tisone G, Otto G, Tsochatzis E, Rossi M, Viveiros A, Ciccarelli O, Cillo U, Lerut J; European Hepatocellular Cancer Liver Transplant Study Group.

Liver Transpl. 2019 Jul;25(7):1023-1033. doi: 10.1002/lt.25492.

PMID:
31087772
4.

Liver transplantation for metastatic wild-type gastrointestinal stromal tumor in the era of molecular targeted therapies: Report of a first case.

Iesari S, Mocchegiani F, Nicolini D, Benedetti Cacciaguerra A, Coletta M, Montalti R, Mandolesi A, Lerut J, Vivarelli M.

Am J Transplant. 2019 Apr 3. doi: 10.1111/ajt.15377. [Epub ahead of print]

PMID:
30943317
5.

Adult-to-adult living-donor liver transplantation: The experience of the Université catholique de Louvain.

Iesari S, Inostroza Núñez ME, Rico Juri JM, Ciccarelli O, Bonaccorsi-Riani E, Coubeau L, Laterre PF, Goffette P, De Reyck C, Lengelé B, Gianello P, Lerut J.

Hepatobiliary Pancreat Dis Int. 2019 Apr;18(2):132-142. doi: 10.1016/j.hbpd.2019.02.007. Epub 2019 Feb 28.

PMID:
30850341
6.

Transplant Surgeon Burnout and Marital Distress in the Sandwich Generation: The Call for Organizational Support in Family Life.

Jesse MT, Shkokani L, Eshelman A, De Reyck C, Abouljoud M, Lerut J.

Transplant Proc. 2018 Dec;50(10):2899-2904. doi: 10.1016/j.transproceed.2018.01.053. Epub 2018 Mar 9.

PMID:
30577147
7.

Vascular tumours of the liver: a particular story.

Lerut J, Iesari S.

Transl Gastroenterol Hepatol. 2018 Sep 14;3:62. doi: 10.21037/tgh.2018.09.02. eCollection 2018. Review.

8.

Hereditary Hemorrhagic Telangiectasia: Time Not Only to Recognize the Disease but Also to Prioritize the Symptomatic Patient on the Waiting List.

Lerut JP.

Transplantation. 2019 Jul;103(7):1302-1303. doi: 10.1097/TP.0000000000002492. No abstract available.

PMID:
30335700
9.

Tacrolimus and Single Intraoperative High-dose of Anti-T-lymphocyte Globulins Versus Tacrolimus Monotherapy in Adult Liver Transplantation: One-year Results of an Investigator-driven Randomized Controlled Trial.

Iesari S, Ackenine K, Foguenne M, De Reyck C, Komuta M, Bonaccorsi Riani E, Ciccarelli O, Coubeau L, Lai Q, Gianello P, Lerut J.

Ann Surg. 2018 Nov;268(5):776-783. doi: 10.1097/SLA.0000000000002943.

PMID:
30307410
10.

2018 Annual Report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation.

Adam R, Karam V, Cailliez V, O Grady JG, Mirza D, Cherqui D, Klempnauer J, Salizzoni M, Pratschke J, Jamieson N, Hidalgo E, Paul A, Andujar RL, Lerut J, Fisher L, Boudjema K, Fondevila C, Soubrane O, Bachellier P, Pinna AD, Berlakovich G, Bennet W, Pinzani M, Schemmer P, Zieniewicz K, Romero CJ, De Simone P, Ericzon BG, Schneeberger S, Wigmore SJ, Prous JF, Colledan M, Porte RJ, Yilmaz S, Azoulay D, Pirenne J, Line PD, Trunecka P, Navarro F, Lopez AV, De Carlis L, Pena SR, Kochs E, Duvoux C; all the other 126 contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA).

Transpl Int. 2018 Dec;31(12):1293-1317. doi: 10.1111/tri.13358.

PMID:
30259574
11.

Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation.

Manzia TM, Angelico R, Toti L, Angelico C, Quaranta C, Parente A, Blasi F, Iesari S, Sforza D, Baiocchi L, Lerut J, Tisone G.

Liver Transpl. 2018 Sep;24(9):1199-1208. doi: 10.1002/lt.25293.

PMID:
30129171
12.

Technical Aspects of Orthotopic Liver Transplantation-a Survey-Based Study Within the Eurotransplant, Swisstransplant, Scandiatransplant, and British Transplantation Society Networks.

Czigany Z, Scherer MN, Pratschke J, Guba M, Nadalin S, Mehrabi A, Berlakovich G, Rogiers X, Pirenne J, Lerut J, Mathe Z, Dutkowski P, Ericzon BG, Malagó M, Heaton N, Schöning W, Bednarsch J, Neumann UP, Lurje G.

J Gastrointest Surg. 2019 Mar;23(3):529-537. doi: 10.1007/s11605-018-3915-6. Epub 2018 Aug 10.

PMID:
30097968
13.

Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.

Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, Xie H, Chen X, Shao L, Zhang R, Xu S, Zhang H, Cui G, Chen X, Sun R, Wen H, Lerut JP, Kan Q, Li L, Zheng S.

Gut. 2019 Jun;68(6):1014-1023. doi: 10.1136/gutjnl-2017-315084. Epub 2018 Jul 25.

14.

Total hepatectomy and modified temporary porto-caval shunt as a useful bridge to urgent retransplantation.

Iesari S, Foguenne M, Lerut J.

Hepatobiliary Pancreat Dis Int. 2018 Aug;17(4):376-377. doi: 10.1016/j.hbpd.2018.06.007. Epub 2018 Jul 8. No abstract available.

PMID:
30031671
15.

Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study.

Manzia TM, Lai Q, Iesari S, Perera MTPR, Komuta M, Carvalheiro A, Shah T, Angelico R, Quaranta C, Nicolini D, Montalti R, Scarpelli M, Palmieri G, Orlacchio A, Vivarelli M, Angelico M, Lerut J, Tisone G.

Transpl Int. 2018 Mar 23. doi: 10.1111/tri.13153. [Epub ahead of print]

16.

Restructuring training in transplantation surgery …and medicine: a necessity on both sides of the Atlantic.

Lerut J.

Transpl Int. 2018 May;31(5):570-572. doi: 10.1111/tri.13139. No abstract available.

17.

Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression?

Lerut J, Iesari S, Foguenne M, Lai Q.

Transl Gastroenterol Hepatol. 2017 Oct 12;2:80. doi: 10.21037/tgh.2017.09.06. eCollection 2017. Review.

18.

Which Is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation?

Lai Q, Vitale A, Rossi M, Cillo U, Lerut J; European Hepatocellular Cancer Liver Transplantation (EurHeCaLT) Study Group.

Ann Surg. 2018 Dec;268(6):e56-e57. doi: 10.1097/SLA.0000000000002575. No abstract available.

PMID:
29064905
19.

The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution.

Lai Q, Iesari S, Melandro F, Mennini G, Rossi M, Lerut J.

Transl Gastroenterol Hepatol. 2017 Sep 16;2:72. doi: 10.21037/tgh.2017.09.05. eCollection 2017. Review.

20.

Gastrointestinal tract post-transplant lymphoproliferative disorder after liver transplantation.

Xie QF, Chen P, Chen XH, Liu JM, Lerut J, Zheng SS.

Hepatobiliary Pancreat Dis Int. 2017 Oct 15;16(5):556-558. doi: 10.1016/S1499-3872(17)60063-8. No abstract available.

PMID:
28992890

Supplemental Content

Support Center